DIA 2018 Global Annual Meeting
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
Special Population Study Challenges
William B. Smith, MD
Alliance for Multispecialty Research/NOCCR, United States
Early phase pharmacokinetic studies continue to be challenging. Current issues from regulatory, CRO/Sponsor, and site perspectives will be discussed and suggestions for optimizing protocols and operations will be presented.
Learning Objective : Describe the design challenges of special population studies; Develop practical solutions to special population study obstacles.
Critical Challenges in Conducting PK Studies in Patients and Special Populations
Charu Gautam, MD
Head- Early Clinical Development, Asia Pacific
Special Population Studies: Thirty Years Experience Shared
Harry Alcorn, PharmD
Chief Scientific Officer
DaVita Clinical Research, United States